| Aubrey Bartel, PT, DPT | |
|
225 N Moonlight Rd, Gardner, KS 66030-1928 | |
| (913) 856-7927 | |
| Not Available |
| Full Name | Aubrey Bartel |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 225 N Moonlight Rd, Gardner, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316626039 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 11-07386 (Kansas) | Primary |
| 225100000X | Physical Therapist | 2023028065 (Missouri) | Secondary |
| Provider Name | Exercise Therapy Consultants Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1962414250 PECOS PAC ID: 1557269255 Enrollment ID: O20170929003392 |
News Archive
Prof. Dr Mikhail Yakimov, a researcher from the Immanuel Kant Baltic Federal University, together with his colleagues from the Heinrich Heine University Düsseldorf, Norwegian Research Centre NORCE AS, School of Natural Sciences of CEU San Pablo University and Institute of Catalysis and Petrochemistry in Madrid (Spain), has conducted a study of universal transaminase enzymes.
Specialized Products Company (SPC), www.specialized.net, which offers the most comprehensive selection of off-the-shelf tool kit solutions for professional system integrators and installers, has added the PT-7500 commercial and industrial labeling tool to its 2010 source book catalog offerings.
In the last decade, a new strain of MRSA has emerged that can spread beyond hospital walls, putting everyone at risk of contracting the dangerous bacterial infection. This particular strain of MRSA - known as USA300 - contains a chunk of genes not shared by any other strains, though it is unclear how this unique genetic material enables the bacteria to survive and persist in the community.
Grifols today announced availability of its recently approved Flebogamma® 10% DIF intravenous immune globulin. Grifols is a global healthcare company specializing in bioscience medicines derived from human plasma. Approval from the US Food and Drug Administration (FDA) for Flebogamma® 10% DIF was obtained in July 2010 and final approval in Europe is expected before the end of the year. Today's announcement signals widespread product availability to the US market.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aubrey Bartel, PT, DPT 1200 Corporate Dr Ste 400, Hoover, AL 35242-5424 Ph: (423) 238-7217 | Aubrey Bartel, PT, DPT 225 N Moonlight Rd, Gardner, KS 66030-1928 Ph: (913) 856-7927 |
News Archive
Prof. Dr Mikhail Yakimov, a researcher from the Immanuel Kant Baltic Federal University, together with his colleagues from the Heinrich Heine University Düsseldorf, Norwegian Research Centre NORCE AS, School of Natural Sciences of CEU San Pablo University and Institute of Catalysis and Petrochemistry in Madrid (Spain), has conducted a study of universal transaminase enzymes.
Specialized Products Company (SPC), www.specialized.net, which offers the most comprehensive selection of off-the-shelf tool kit solutions for professional system integrators and installers, has added the PT-7500 commercial and industrial labeling tool to its 2010 source book catalog offerings.
In the last decade, a new strain of MRSA has emerged that can spread beyond hospital walls, putting everyone at risk of contracting the dangerous bacterial infection. This particular strain of MRSA - known as USA300 - contains a chunk of genes not shared by any other strains, though it is unclear how this unique genetic material enables the bacteria to survive and persist in the community.
Grifols today announced availability of its recently approved Flebogamma® 10% DIF intravenous immune globulin. Grifols is a global healthcare company specializing in bioscience medicines derived from human plasma. Approval from the US Food and Drug Administration (FDA) for Flebogamma® 10% DIF was obtained in July 2010 and final approval in Europe is expected before the end of the year. Today's announcement signals widespread product availability to the US market.
› Verified 8 days ago
Kelly Anne Yates, PT, MSPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 225 N Moonlight Rd, Gardner, KS 66030 Phone: 913-856-7927 Fax: 913-856-8442 | |
Sandra Billinger, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 223 Bedford St, Gardner, KS 66030 Phone: 615-896-6400 | |
Erin Anne Nichols, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 225 N Moonlight Rd, Gardner, KS 66030 Phone: 913-856-7927 Fax: 913-856-8442 | |
Ryan Barragree, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 824 E Main St, Gardner, KS 66030 Phone: 913-324-8680 | |
Karley Lynn Perry, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 225 N Moonlight Rd, Gardner, KS 66030 Phone: 913-856-7927 Fax: 913-856-8442 | |
Jamie F Konrade, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 223 Bedford St, Gardner, KS 66030 Phone: 615-896-6400 |